drug development

WuXi STA’s Facility Passes Fourth US FDA Inspection

The Jinshan facility is equipped with more than 100 modern reactors for drug manufacturing and houses industry-leading technology platforms for flow chemistry and biocatalysis.

WuXi STA And Antengene To Collaborate On Cancer Drug Development

Antengene is tapping on WuXi STA’s end-to-end drug development platform to accelerate the clinical testing and commercialization of cancer drugs.

WuXi To Establish Biologics Center In Northern China

The new biologics center in Shijiazhuang will include process development labs as well as clinical and commercial manufacturing facilities.

CStone Pharma Completes US$260 Million Series B Funding Round

The funds raised will primarily be used for clinical development of CS1001 and other clinical stage assets, as well as attract top industry talents.

WuXi STA Builds A New R&D Center In Shanghai

The new R&D center in Shanghai, China, will enable drug developers to accelerate their projects from preclinical to commercial stage.

WuXi STA & Regulus To Collaborate On MicroRNA-Targeting Drugs

The partnership is aimed at accelerating Regulus’ oligonucleotide therapeutics programs into the clinic for the treatment of a variety of diseases.

Takeda’s Zika Vaccine Moves Into The Fast Lane

TAK-426, Takeda’s Zika vaccine currently in phase 1 trials, has received US Food and Drug Administration’s Fast Track designation.

Chloroquine Blocks Zika Infection In Mice

Scientist in China have demonstrated that the FDA-approved drug chloroquine prevents Zika virus infection and its associated congenital microcephaly in mice.

Photosensitizer Enhances Cancer-Killing Ability Of Malaria Drug

By combining the anti-malarial drug artemisinin with a photosensitizer, researchers from Singapore have multiplied its cancer-killing ability ten-fold.